Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.05.2015 | Case report

Capecitabine/cisplatin

Neutropenia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat McPartlin AJ, et al. Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: Experience outside of a trial setting. Chemotherapy (Basel) 59: [7 pages], No. 1, Aug 2013. Available from: URL: http://doi.org/10.1159/000348816 - United Kingdom McPartlin AJ, et al. Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: Experience outside of a trial setting. Chemotherapy (Basel) 59: [7 pages], No. 1, Aug 2013. Available from: URL: http://​doi.​org/​10.​1159/​000348816 - United Kingdom
Metadaten
Titel
Capecitabine/cisplatin
Neutropenia: case report
Publikationsdatum
01.05.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-1839-4

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Mineral oil

Case report

Methotrexate